Prof Alwin Krämer presents at ecancer's Milan Summit on Precision Medicine 2018 about cancers of unknown primary (CUP), where the initial tumour of a metastasised cancer cannot be identified.
He outlines the few data available on CUP syndrome, with some insight on an upcoming genomic based clinic trial surrounding CUP.
The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine